An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users injecting products of unknown origin.
Several professionals stated the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the platform has removed problematic content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Trading Activities
Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.
After moments of joining one community, a seller shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Costs
Within these communities, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has already encountered patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially serious medical dangers”.
